InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+10.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Whitley Richard James, Director. Insider active across 2 companies, notably Gilead Sciences INC. In total, 10 filings have been logged. Split: 5 buys · 1 sell. Total volume traded: €23k. Activity tracked since 3 May 2021. The latest transaction was disclosed on 8 December 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
1,800 shares@ US$0.25911.9% of flowCommon StockSEC:0001415889-22-012370:0
500 shares@ US$4.5259.7% of flowCommon StockSEC:0001415889-22-005275:0
Ideal exit: 12 Feb 2023 (T+270)
1,800 shares@ US$5.7290.0% of flowCommon StockSEC:0001415889-22-000447
Ideal exit: 3 Oct 2022 (T+270)
1,800 shares@ US$5.7240.7% of flowCommon StockSEC:0001415889-22-000447:0
Ideal exit: 3 Oct 2022 (T+270)
200 shares@ US$5.72510.0% of flowCommon StockSEC:0001415889-21-006204
Ideal exit: 19 Sept 2022 (T+270)
200 shares@ US$5.7254.5% of flowCommon StockSEC:0001415889-21-006204:0
Ideal exit: 19 Sept 2022 (T+270)
1,936 sharesCommon StockSEC:0001127602-21-015952:0
1,936 sharesCommon StockSEC:0001127602-21-015952
20,282 shares@ US$20.64550.0% of flowCommon StockSEC:0001127602-21-015340
20,282 shares@ US$20.6450.0002% mcap50.0% of flowCommon StockSEC:0001127602-21-015340:0
10 of 10 declarations
About Whitley Richard James
Richard James Whitley is a Board Member at Gilead Sciences Inc and Virios Therapeutics, Inc. He has significant experience in the biopharmaceutical sector. As a board member, he is involved in overseeing operations and strategic decision-making. His expertise in life sciences is valuable in guiding these companies towards sustainable growth.
